Grant Avenue Capital Portfolio

Grant Avenue Capital Portfolio Summary

Grant Avenue Capital’s most common sectors for investment arehealthcare services (75%) and life science (25%) . The Firm’s most common investment types include divestiture (75%) and consolidation (25%). In total, Grant Avenue Capital has invested in 4 US states.

Sign-up to view Grant Avenue Capital’s full profile and discover more middle-market private equity firm investors just like it.

Portfolio Summary

  • Total Sectors Invested 2
  • Total Countries Invested 1

Grant Avenue Capital

Grant Avenue Capital LLC

444 Madison Ave., Suite #3300,
New York, New York 10022
United States
(212) 630-8935
www.grantavecap.com
info@grantavecap.com

All (4) Current (4) Exited (0)
Status Dates Company Description
Investment    Exit       
Current 2022-11-17 - Helios Clinical Research
Life Science
New York, New York
www.heliosclinical.com
Helios Clinical Research is an integrated clinical site organization that partners with patients, physicians, and biopharma sponsors to optimize clinical research. Helios Clinical Research was founded in 2022 and is based in New York City.


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.